Maravai LifeSciences Holdings, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
260.15 |
194.72 |
215.56 |
242.26 |
236.50 |
256.10 |
| Przychód Δ r/r |
0.00% |
-25.15% |
10.70% |
12.39% |
-2.38% |
8.29% |
| Przychód (min) |
259.90 |
171.47 |
200.99 |
240.59 |
217.09 |
235.08 |
| Przychód (max) |
260.50 |
206.35 |
234.16 |
243.94 |
252.14 |
273.03 |
| EBITDA (średnia) |
119.93 |
89.77 |
99.37 |
111.68 |
109.03 |
118.06 |
| EBIT (średnia) |
99.93 |
74.79 |
82.80 |
93.06 |
90.84 |
98.37 |
| EBIT % |
38.41% |
38.41% |
38.41% |
38.41% |
38.41% |
38.41% |
| Zysk netto (średni) |
-11.58 |
-39.47 |
-37.26 |
-29.97 |
-47.58 |
-45.51 |
| Zysk netto % |
-4.45% |
-20.27% |
-17.29% |
-12.37% |
-20.12% |
-17.77% |
| EPS (średnia) |
-0.08 |
-0.29 |
-0.23 |
-0.22 |
-0.34 |
-0.33 |
| Liczba analityków (Przychody) |
10 |
9 |
12 |
6 |
2 |
5 |
| Liczba analityków (EPS) |
8 |
9 |
8 |
2 |
1 |
1 |
| symbol |
MRVI |
MRVI |
MRVI |
MRVI |
MRVI |
MRVI |